Posts

Showing posts from June, 2021

Latin America Generic Injectables Market 2021-2026: Share, Trends, Industry Analysis & Growth

Image
  According to the latest report by IMARC Group, titled  “ Latin America Generic Injectables Market Report : Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026, ” the market is expected to continue its robust growth in the forecast period (2021-2026). Generic injectables are pharmaceutical drugs with the same active ingredients, strength, dosage, and administration route as of branded injectables. Some of their standard products include Prevnar 13, Eliquis, Ibrance, Lyrica, Xeljanz, etc. Generic injectables facilitate the quick onset of action, precise and adjustable dosing, and predictable bioavailability. Moreover, these injectables cost lesser than their branded counterparts, which aids in managing overhead costs related to pharma products. As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the industry behaviours of the consumers globally and our estimates about the latest m

Europe Organ Preservation Market: Industry Opportunity, Growth, Analysis and Forecast 2021-2026

Image
According to the latest report by IMARC Group, titled  “ Europe Organ Preservation Market Size : Industry Trends, Share, Growth, Opportunity and Forecast 2021-2026, ” the europe organ preservation market is expected to continue its moderate growth during the forecast period (2021-2026). Organ preservation is the process by which the viability of harvested organs is maintained to ensure that the organ functions normally after transplantation. This procedure involves removing an organ from the donor’s body, followed by its storage and transportation, to finally its transplantation into the receiver’s body. The process of organ preservation utilizes various techniques, such as hypothermic machine perfusion, normothermic machine perfusion (NMP), static cold storage (SCS), etc. These techniques help in maintaining the temperature and oxygen levels of the organ while increasing the receiver’s chances of survival. As the novel coronavirus (COVID-19) crisis takes over the world, we are co

India Organ Preservation Market, Industry Overview, Share, Growth and Forecast 2021-2026

Image
According to the latest report by IMARC Group, titled  “ India Organ Preservation Market Growth : Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026, ” the india organ preservation market is expected to continue its strong growth during the forecast period (2021-2026).   Organ preservation involves maintaining the viability and health of an organ harvested from a donor's body for transplanting them into the body of a receiver. The procedure requires removing organs and storing them in static cold storage (SCS) before transporting them for transplantation surgery. This prevents the breakdown of healthy tissues by harmful metabolites, enhancing the ability to restore normal organ functionality after transplantation. Various techniques, such as hypothermic machine perfusion, static cold storage (SCS), normothermic machine perfusion (NMP), etc., are used for maintaining the organ's temperature and oxygen levels. Apart from this, other special solutions are

India Generic Injectables Market Overview 2021: Size, Share, Growth and Forecast 2026

Image
According to the latest report by IMARC Group, titled  “ India Generic Injectables Market Size : Industry Trends, Share, Growth, Opportunity and Forecast 2021-2026, ” the india generic injectables market is expected to continue its robust growth in the forecast period (2021-2026). Generic injectables are pharmaceutical drugs with the similar active ingredients, strength, dosage, and administration route as that of their branded injectables. Some of common product variants, include Prevnar 13, Eliquis, Ibrance, Lyrica, Xeljanz, etc. Generic injectables facilitate the quick onset of action, precise and adjustable dosing, and predictable bioavailability. Moreover, these injectables cost lesser than their branded counterparts, which helps in managing overhead costs related to pharma products. As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the industry behaviours of the consumers globally and our esti